1999 WHO/ISH hypertension guidelines - highlights & esh update

被引：23

作者：

Kjeldsen, SE ^{[1
]}

Farsang, C

Sleigh, P

Mancia, G

机构：

[1] Ullevaal Univ Hosp, Dept Cardiol, Oslo, Norway

[2] Istanbul Univ, Cardiol Inst, Istanbul, Turkey

[3] St Imre Teaching Hosp, Dept Internal Med, Budapest, Hungary

[4] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England

[5] Univ Milan, Osped S Gerardo, Med Clin, Monza, Italy

来源：

JOURNAL OF HYPERTENSION | 2001年 / 19卷 / 12期

关键词：

D O I：

10.1097/00004872-200112000-00026

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

[No abstract available]

引用

页码：2285 / 2288

页数：4

共 14 条

[1] Effects of an ACE inhibitor calcium antagonist combination on proteinuria in diabetic nephropathy [J].

Bakris, GL ;

Weir, MR ;

DeQuattro, V ;

McMahon, FG .

KIDNEY INTERNATIONAL, 1998, 54 (04) :1283-1289

[2] Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) [J].

Brown, MJ ;

Palmer, CR ;

Castaigne, A ;

de Leeuw, PW ;

Mancia, G ;

Rosenthal, T ;

Ruilope, LM .

LANCET, 2000, 356 (9227) :366-372

[3]

Chalmers J, 1999, J HYPERTENS, V17, P151

[4]

Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967

[5]

Gerstein HC, 2000, LANCET, V355, P253

[6] Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension:: the Nordic Diltiazem (NORDIL) study [J].

Hansson, L ;

Hedner, T ;

Lund-Johansen, P ;

Kjeldsen, SE ;

Lindholm, LH ;

Syvertsen, JO ;

Lanke, J ;

de Faire, U ;

Dahlöf, B ;

Karlberg, BE .

LANCET, 2000, 356 (9227) :359-365

[7] Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension:: the Captopril Prevention Project (CAPPP) randomised trial [J].

Hansson, L ;

Lindholm, LH ;

Niskanen, L ;

Lanke, J ;

Hedner, T ;

Niklason, A ;

Luomanmäki, K ;

Dahlöf, B ;

de Faire, U ;

Mörlin, C ;

Karlberg, BE ;

Wester, PO ;

Björck, JE .

LANCET, 1999, 353 (9153) :611-616

[8] Randomised trial of old and new antihypertensive drugs in elderly patients:: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study [J].

Hansson, L ;

Lindholm, LH ;

Ekbom, T ;

Dahlöf, B ;

Lanke, J ;

Scherstén, B ;

Wester, PO ;

Hedner, T ;

de Faire, U .

LANCET, 1999, 354 (9192) :1751-1756

[9] Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].

Hansson, L ;

Zanchetti, A ;

Carruthers, SG ;

Dahlöf, B ;

Elmfeldt, D ;

Julius, S ;

Ménard, J ;

Rahn, KH ;

Wedel, H ;

Westerling, S .

LANCET, 1998, 351 (9118) :1755-1762

[10] Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study [J].

Kjeldsen, SE ;

Kolloch, RE ;

Leonetti, G ;

Mallion, JM ;

Zanchetti, A ;

Elmfeldt, D ;

Warnold, I ;

Hansson, L .

JOURNAL OF HYPERTENSION, 2000, 18 (05) :629-642

← 1 2 →